Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - INTEREST INCOME & EXPENSE
Interest Income & Expense KYMR - Kymera Therapeutics, Inc.
196 K
LAST VALUE
5.83%
2 YEAR CAGR
65.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR